Free Trial

Royal Bank Of Canada Reaffirms Sector Perform Rating for Marlowe (LON:MRL)

Marlowe logo with Industrials background

Marlowe (LON:MRL - Get Free Report)'s stock had its "sector perform" rating restated by equities research analysts at Royal Bank Of Canada in a research note issued to investors on Wednesday, MarketBeat.com reports. They presently have a GBX 466 ($6.26) price objective on the stock. Royal Bank Of Canada's price objective suggests a potential upside of 5.67% from the company's previous close.

Marlowe Stock Performance

Shares of MRL traded up GBX 1 ($0.01) during mid-day trading on Wednesday, hitting GBX 441 ($5.92). 279,322 shares of the company's stock were exchanged, compared to its average volume of 735,042. Marlowe has a 52 week low of GBX 220 ($2.95) and a 52 week high of GBX 490 ($6.58). The stock's 50-day simple moving average is GBX 412.73 and its 200-day simple moving average is GBX 357.67. The firm has a market cap of £352.89 million, a price-to-earnings ratio of -41.02 and a beta of 0.44. The company has a quick ratio of 0.80, a current ratio of 1.24 and a debt-to-equity ratio of 58.99.

Marlowe (LON:MRL - Get Free Report) last announced its quarterly earnings data on Thursday, June 26th. The company reported GBX 15.30 ($0.21) earnings per share (EPS) for the quarter. Marlowe had a negative net margin of 2.03% and a negative return on equity of 2.33%. On average, equities research analysts expect that Marlowe will post 12.4863487 EPS for the current year.

Marlowe Company Profile

(Get Free Report)

Marlowe is a leader in business-critical services and software which assure regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services and software. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation.

Featured Stories

Should You Invest $1,000 in Marlowe Right Now?

Before you consider Marlowe, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marlowe wasn't on the list.

While Marlowe currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines